{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:48:50Z","timestamp":1761630530033},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.eimc.2008.05.004","type":"journal-article","created":{"date-parts":[[2009,9,23]],"date-time":"2009-09-23T21:01:54Z","timestamp":1253739714000},"page":"89-104","source":"Crossref","is-referenced-by-count":21,"title":["Diagn\u00f3stico microbiol\u00f3gico de la colonizaci\u00f3n-infecci\u00f3n broncopulmonar en el paciente con fibrosis qu\u00edstica"],"prefix":"10.1016","volume":"27","author":[{"given":"Antonio","family":"Oliver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estrella","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Cant\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2008.05.004_bib1","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.eimc.2008.05.004_bib2","unstructured":"Cystic Fibrosis Foundation, Patient Registry Annual Report. Bethesda, Maryland; 2005."},{"key":"10.1016\/j.eimc.2008.05.004_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CMR.15.2.194-222.2002","article-title":"Lung infections associated with cystic fibrosis","volume":"15","author":"Lyczak","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimc.2008.05.004_bib4","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00063198-200311000-00007","article-title":"Update on pathogenesis of cystic fibrosis lung disease","volume":"9","author":"Donaldson","year":"2003","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.eimc.2008.05.004_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.4.1.35","article-title":"Microbiology of airway disease in patients with cystic fibrosis","volume":"4","author":"Gilligan","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimc.2008.05.004_bib6","series-title":"Fibrosis qu\u00edstica: atenci\u00f3n integral. Manejo cl\u00ednico y puesta al d\u00eda","first-page":"105","article-title":"Microbiolog\u00eda de las v\u00edas respiratorias en la fibrosis qu\u00edstica","author":"Cant\u00f3n","year":"1998"},{"key":"10.1016\/j.eimc.2008.05.004_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2217\/17460913.2.2.153","article-title":"Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection","volume":"2","author":"Govan","year":"2007","journal-title":"Future Microbiol"},{"key":"10.1016\/j.eimc.2008.05.004_bib8","series-title":"Evolutionary biology of bacterial and fungal pathogens","article-title":"Evolution of Pseudomonas aeruginosa pathogenicity: from acute to chronic infections","author":"Oliver","year":"2007"},{"key":"10.1016\/j.eimc.2008.05.004_bib9","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1128\/IAI.67.9.4744-4750.1999","article-title":"Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype","volume":"67","author":"Parad","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.eimc.2008.05.004_bib10","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1073\/pnas.0602138103","article-title":"Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients","volume":"103","author":"Smith","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.eimc.2008.05.004_bib11","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1126\/science.288.5469.1251","article-title":"High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection","volume":"288","author":"Oliver","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.eimc.2008.05.004_bib12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1128\/AAC.50.3.975-983.2006","article-title":"Efficacy and potential for resistance selection of anti-pseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa","volume":"50","author":"Maci\u00e1","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.05.004_bib13","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1128\/AAC.49.8.3382-3386.2005","article-title":"Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections","volume":"49","author":"Maci\u00e1","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.05.004_bib14","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1128\/IAI.74.5.2568-2577.2006","article-title":"Staphylococcus aureus escapes more efficiently from the phagosome of a cystic fibrosis bronchial ephitelial cell line than from its normal counterpart","volume":"74","author":"Jarry","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.eimc.2008.05.004_bib15","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/374937","article-title":"High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains","volume":"187","author":"Prunier","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2008.05.004_bib16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/515238","article-title":"Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis","volume":"177","author":"Kahl","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2008.05.004_bib17","unstructured":"Gillian PH, Kiska DL, Appleman MD. Cumitech 43, Cystic fibrosis microbiology. Appleman MD, coordinador editor. American Society for Microbiology; 2006."},{"key":"10.1016\/j.eimc.2008.05.004_bib18","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/infdis\/172.5.1388","article-title":"Multiple Haemophilus influenzae strains and strain variants coexist in the respiratory tract of patients with cystic fibrosis","volume":"172","author":"M\u00f6ller","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2008.05.004_bib19","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1128\/JCM.42.4.1450-1459.2004","article-title":"Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains","volume":"42","author":"Rom\u00e1n","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2008.05.004_bib20","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1128\/AAC.01437-06","article-title":"Fluoroquinolone resistance in Haemophilus influenzae is associated with hypermutability","volume":"51","author":"P\u00e9rez-V\u00e1zquez","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.05.004_bib21","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1128\/JCM.43.5.2207-2214.2005","article-title":"Spanish Pneumococcal Infection Study Network. Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients","volume":"43","author":"Del Campo","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2008.05.004_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jac\/dkl482","article-title":"Differences in biofilm development and antibiotic susceptibility among Streptococcus pneumoniae isolates from cystic fibrosis samples and blood cultures","volume":"59","author":"Garcia-Castillo","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2008.05.004_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1034\/j.1399-3062.2001.003003149.x","article-title":"Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis?","volume":"3","author":"LiPuma","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.eimc.2008.05.004_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/CMR.17.1.57-71.2004","article-title":"Infection control in cystic fibrosis","volume":"17","author":"Saiman","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimc.2008.05.004_bib25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00063198-200011000-00015","article-title":"Unusual respiratory bacterial flora in cystic fibrosis: microbiologic and clinical features","volume":"6","author":"Beringer","year":"2000","journal-title":"Curr Op Pulm Med"},{"key":"10.1016\/j.eimc.2008.05.004_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3201\/eid0701.010116","article-title":"Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991\u20131998","volume":"7","author":"Valdezate","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.eimc.2008.05.004_bib27","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1164\/rccm.200207-678OC","article-title":"Nontuberculous Mycobacteria. I: Multicenter prevalence study in cystic fibrosis","volume":"167","author":"Olivier","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.eimc.2008.05.004_bib28","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1128\/JCM.43.7.3467-3470.2005","article-title":"Age-related prevalence and distribution of nontuberculous mycobacteria species among patients with cystic fibrosis","volume":"43","author":"Pierre-Audigier","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2008.05.004_bib29","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1086\/319987","article-title":"Nontuberculous mycobacteria in patients with cystic fibrosis","volume":"32","author":"Oliver","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.eimc.2008.05.004_bib30","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary Aspergillosis in cystic fibrosis\u2013 state of de art: Cystic Fibrosis Foundation Consensus Conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.05.004_bib31","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/ppul.20517","article-title":"Viral and atypical bacterial infections in the outpatients pediatric cystic fibrosis clinic","volume":"41","author":"Olesen","year":"2006","journal-title":"Pediatric Pulmonology"},{"key":"10.1016\/j.eimc.2008.05.004_bib32","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1157\/13125641","article-title":"Diagn\u00f3stico microbiol\u00f3gico de las infecciones bacterianas del tracto respiratorio inferior","volume":"26","author":"Meseguer","year":"2008","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2008.05.004_bib33","unstructured":"Alarc\u00f3n T, Caballero E, Cant\u00f3n R, Oliver A. Diagn\u00f3stico microbiol\u00f3gico de la colonizaci\u00f3n-infecci\u00f3n broncopulmonar en el paciente con fibrosis qu\u00edstica. En: Cercenado E, Cant\u00f3n R, editores. Procedimientos en Microbiolog\u00eda Cl\u00ednica n.o 25. 2.a ed. Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica (SEIMC). Disponible en: http:\/\/www.seimc.org\/documentos\/index.asp?apV=documentos&apV1=documentos&apnv0=documentos_index_txt.htm."},{"key":"10.1016\/j.eimc.2008.05.004_bib34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0732-8893(01)00234-6","article-title":"Comparison of two comertial systems (vitek and MicroScan-Walkaway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients","volume":"39","author":"Burns","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2008.05.004_bib35","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1128\/JCM.43.9.4480-4485.2005","article-title":"Breakpoints for predicting Pseudomonas aeruginosa susceptibility to inhaled tobramycin in cystic fibrosis patients: use of high-range Etest strips","volume":"43","author":"Morosini","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2008.05.004_bib36","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1128\/AAC.48.7.2665-2672.2004","article-title":"Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion","volume":"48","author":"Maci\u00e1","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.05.004_bib37","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/JCM.37.6.1771-1776.1999","article-title":"The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms","volume":"37","author":"Ceri","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2008.05.004_bib38","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1128\/JCM.42.5.1915-1922.2004","article-title":"Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis","volume":"42","author":"Moskowitz","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2008.05.004_bib39","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1469-0691.2005.01217.x","article-title":"Spanish Consensus Group for Antimicrobial Therapy in the Cystic Fibrosis Patient. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients","volume":"11","author":"Cant\u00f3n","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2008.05.004_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcf.2005.05.009","article-title":"Detection of Pseudomonas aeruginosa in patients with cystic fibrosis","volume":"4","author":"Tramper-Stranders","year":"2005","journal-title":"J Cyst Fibr"},{"key":"10.1016\/j.eimc.2008.05.004_bib41","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1128\/JCM.38.9.3165-3173.2000","article-title":"DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III","volume":"38","author":"Mahenthiralingam","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2008.05.004_bib42","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1099\/jmm.0.46457-0","article-title":"Identification of Burkholderia cepacia complex pathogens by rapid-cycle PCR with fluorescent hybridization probes","volume":"55","author":"Vonberg","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.eimc.2008.05.004_bib43","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/jac\/dkn081","article-title":"Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media","volume":"61","author":"Perry","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2008.05.004_bib44","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1001\/jama.287.22.2958","article-title":"Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis. Early detection by serology and assessment of risk factors","volume":"287","author":"West","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2008.05.004_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ppul.20562","article-title":"Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"42","author":"Ratjen","year":"2007","journal-title":"Pediatric Pulmonol"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X08000281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X08000281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T12:19:22Z","timestamp":1590149962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X08000281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0213005X08000281"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2008.05.004","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}